Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Surgery Partners (SGRY) Operating Leases: 2019-2025

Historic Operating Leases for Surgery Partners (SGRY) over the last 7 years, with Q3 2025 value amounting to $1.2 billion.

  • Surgery Partners' Operating Leases rose 1570.29% to $1.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 billion, marking a year-over-year increase of 1570.29%. This contributed to the annual value of $1.1 billion for FY2024, which is 1547.8% up from last year.
  • Latest data reveals that Surgery Partners reported Operating Leases of $1.2 billion as of Q3 2025, which was up 1570.29% from $1.2 billion recorded in Q2 2025.
  • Surgery Partners' 5-year Operating Leases high stood at $1.2 billion for Q3 2025, and its period low was $295.4 million during Q1 2021.
  • For the 5-year period, Surgery Partners' Operating Leases averaged around $864.2 million, with its median value being $893.6 million (2022).
  • Its Operating Leases has fluctuated over the past 5 years, first surged by 18508.32% in 2022, then surged by 177.38% in 2023.
  • Surgery Partners' Operating Leases (Quarter) stood at $720.3 million in 2021, then grew by 24.06% to $893.6 million in 2022, then rose by 9.68% to $980.1 million in 2023, then grew by 15.48% to $1.1 billion in 2024, then grew by 7.48% to $1.2 billion in 2025.
  • Its last three reported values are $1.2 billion in Q3 2025, $1.2 billion for Q2 2025, and $1.2 billion during Q1 2025.